13 drug(s) with this reaction
29,288 total reports
Drug Ineffective has been reported as an adverse reaction across 13 drug(s) manufactured by Amgen Inc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 29,288 adverse event reports mention drug ineffective in connection with Amgen Inc products.
This page provides a breakdown of which Amgen Inc drugs are most commonly associated with drug ineffective, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Amgen Inc drugs have drug ineffective listed in their FDA adverse event reports, sorted by report count:
In addition to drug ineffective, the following adverse reactions have been reported across Amgen Inc's drug portfolio:
13 drug(s) manufactured by Amgen Inc have drug ineffective listed in their FDA adverse event reports: APREMILAST, ERENUMAB-AOOE, DENOSUMAB, ROMIPLOSTIM, FILGRASTIM, and others.
There are a combined 29,288 reports of drug ineffective across 13 Amgen Inc drug(s) in the FDA adverse event database.